Ultragenyx Pharmaceutical, Inc. Stock Chart

Ultragenyx Pharmaceutical, Inc. (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About Ultragenyx Pharmaceutical, Inc.

LSE
Market Cap
$3.01B
Shares Out.
96.37M
Sector
Health Technology
Industry
Pharmaceuticals: Major

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

www.ultragenyx.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
0LIF.GB (0LIF.GB) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart